News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
671,608 Results
Type
Article (64973)
Company Profile (132)
Press Release (606489)
Multimedia
Podcasts (84)
Webinars (20)
Section
Business (178562)
Career Advice (2786)
Deals (32030)
Drug Delivery (111)
Drug Development (78845)
Employer Resources (158)
FDA (16693)
Job Trends (14235)
News (314630)
Policy (31247)
Tag
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (2864)
Academic (1)
Accelerated approval (34)
Adcomms (28)
Allergies (138)
Alliances (49712)
ALS (173)
Alzheimer's disease (1720)
Antibody-drug conjugate (ADC) (298)
Approvals (16914)
Artificial intelligence (519)
Autoimmune disease (153)
Automation (34)
Bankruptcy (336)
Best Places to Work (11002)
BIOSECURE Act (21)
Biosimilars (180)
Biotechnology (84)
Bladder cancer (150)
Brain cancer (60)
Breast cancer (623)
Cancer (4763)
Cardiovascular disease (398)
Career advice (2357)
Career pathing (41)
CAR-T (287)
CDC (47)
Celiac Disease (1)
Cell therapy (758)
Cervical cancer (33)
Clinical research (66891)
Collaboration (1727)
Company closure (3)
Compensation (584)
Complete response letters (67)
COVID-19 (2730)
CRISPR (88)
C-suite (811)
Cystic fibrosis (151)
Data (6035)
Decentralized trials (2)
Denatured (28)
Depression (140)
Diabetes (484)
Diagnostics (6330)
Digital health (38)
Diversity (10)
Diversity, equity & inclusion (39)
Drug discovery (258)
Drug pricing (176)
Drug shortages (26)
Duchenne muscular dystrophy (229)
Earnings (68303)
Editorial (61)
Employer branding (19)
Employer resources (143)
Events (88669)
Executive appointments (967)
FDA (19801)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1455)
Gene editing (190)
Generative AI (49)
Gene therapy (608)
GLP-1 (965)
Government (4346)
Grass and pollen (7)
Guidances (383)
Healthcare (17678)
HIV (56)
Huntington's disease (41)
IgA nephropathy (82)
Immunology and inflammation (243)
Immuno-oncology (55)
Indications (101)
Infectious disease (2991)
Inflammatory bowel disease (188)
Inflation Reduction Act (11)
Influenza (112)
Intellectual property (244)
Interviews (526)
IPO (14683)
IRA (43)
Job creations (3563)
Job search strategy (1938)
JPM (61)
Kidney cancer (16)
Labor market (73)
Layoffs (513)
Leadership (37)
Legal (6832)
Liver cancer (93)
Longevity (14)
Lung cancer (637)
Lymphoma (368)
Machine learning (44)
Management (55)
Manufacturing (741)
MASH (162)
Medical device (12285)
Medtech (12332)
Mergers & acquisitions (18351)
Metabolic disorders (1220)
Multiple sclerosis (161)
NASH (19)
Neurodegenerative disease (325)
Neuropsychiatric disorders (84)
Neuroscience (2957)
Neurotech (1)
NextGen: Class of 2026 (6112)
Non-profit (4714)
Now hiring (53)
Obesity (557)
Opinion (297)
Ovarian cancer (161)
Pain (203)
Pancreatic cancer (220)
Parkinson's disease (287)
Partnered (36)
Patents (486)
Patient recruitment (478)
Peanut (56)
People (54663)
Pharmaceutical (39)
Pharmacy benefit managers (28)
Phase 1 (20707)
Phase 2 (29287)
Phase 3 (22077)
Pipeline (5038)
Policy (275)
Postmarket research (2603)
Preclinical (9324)
Press Release (69)
Prostate cancer (236)
Psychedelics (48)
Radiopharmaceuticals (268)
Rare diseases (856)
Real estate (5585)
Recruiting (70)
Regulatory (24480)
Reports (37)
Research institute (2671)
Resumes & cover letters (446)
Rett syndrome (27)
RNA editing (17)
RSV (75)
Schizophrenia (150)
Series A (232)
Series B (173)
Service/supplier (10)
Sickle cell disease (94)
Special edition (24)
Spinal muscular atrophy (170)
Sponsored (45)
Startups (3389)
State (2)
Stomach cancer (12)
Supply chain (98)
Tariffs (70)
The Weekly (55)
Vaccines (1027)
Venture capital (82)
Weight loss (363)
Women's health (83)
Worklife (19)
Date
Today (18)
Last 7 days (527)
Last 30 days (1855)
Last 365 days (28081)
2026 (2642)
2025 (28535)
2024 (32873)
2023 (37231)
2022 (47969)
2021 (51981)
2020 (50719)
2019 (44082)
2018 (33535)
2017 (31243)
2016 (30484)
2015 (35559)
2014 (28272)
2013 (25063)
2012 (25855)
2011 (26568)
2010 (25250)
Location
Africa (920)
Alabama (88)
Alaska (5)
Arizona (235)
Arkansas (12)
Asia (41564)
Australia (7324)
California (9902)
Canada (3128)
China (1101)
Colorado (442)
Connecticut (453)
Delaware (285)
Europe (94327)
Florida (1549)
Georgia (316)
Hawaii (3)
Idaho (56)
Illinois (827)
India (63)
Indiana (469)
Iowa (21)
Japan (409)
Kansas (117)
Kentucky (33)
Louisiana (26)
Maine (74)
Maryland (1255)
Massachusetts (7056)
Michigan (304)
Minnesota (527)
Mississippi (5)
Missouri (124)
Montana (35)
Nebraska (27)
Nevada (116)
New Hampshire (73)
New Jersey (2821)
New Mexico (32)
New York (2757)
North Carolina (1368)
North Dakota (9)
Northern California (4741)
Ohio (317)
Oklahoma (20)
Oregon (40)
Pennsylvania (2011)
Puerto Rico (23)
Rhode Island (40)
South America (1197)
South Carolina (66)
South Dakota (1)
Southern California (3925)
Tennessee (160)
Texas (1642)
United States (35970)
Utah (308)
Vermont (1)
Virginia (252)
Washington D.C. (75)
Washington State (849)
West Virginia (3)
Wisconsin (104)
Wyoming (2)
671,608 Results for "alliance for lupus research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lupus Research Alliance Launches New Philanthropic Fund to Advance Treatments and Diagnostics
January 6, 2026
·
5 min read
Press Releases
Lupus Research Alliance Funds Study to Understand Connection between the Common Epstein-Barr Virus and Lupus
November 13, 2025
·
3 min read
Press Releases
Lupus Research Alliance Showcases Research that will Shape Next Generation Treatments at ACR Convergence 2025
October 22, 2025
·
8 min read
Press Releases
Lupus Research Alliance Grants Lupus Innovation Awards to Eleven Talented Researchers to Accelerate Pace of Discovery in Lupus Research
April 16, 2025
·
7 min read
Press Releases
Lupus Research Alliance Spearheads Groundbreaking Lupus Nexus Foundational Analyses to Accelerate Personalized Lupus Treatments and a Cure
May 21, 2025
·
4 min read
Press Releases
Lupus Research Alliance Grants Inaugural Awards to 11 Researchers Focused on Engineered Cell Therapies for Lupus
March 20, 2025
·
8 min read
Business
Lupus Research Alliance Awards Lupus Insight Prize to Two Trailblazers in CAR T Cell Therapy
The Lupus Research Alliance announced the recipients of the 2024 Lupus Insight Prize to Marko Radic, Ph.D., The University of Tennessee Health Science Center, and Georg Schett, M.D., Friedrich-Alexander-Universität Erlangen-Nürnberg, for their groundbreaking discoveries in utilizing CAR T cell therapy to potentially revolutionize lupus treatment.
June 20, 2024
·
6 min read
Pharm Country
Lupus Research Alliance Announces Recipients of the Lupus Mechanisms and Targets Award
The Lupus Research Alliance is pleased to announce the recent recipients of the Lupus Mechanisms and Targets Award, whose research will investigate molecular pathways or targets that will lead to new or improved therapies for individuals with systemic lupus erythematosus.
February 28, 2024
·
6 min read
Autoimmune disease
Roche’s Gazyva Expands Out of Cancer With FDA Approval for Lupus
The anti-CD20 antibody, developed by Roche’s Genentech along with Biogen and already approved for multiple oncology indications, is branching into autoimmune disease. Its B cell–targeting mechanism of action gives it activity in improving kidney conditions in patients with lupus nephritis.
October 20, 2025
·
2 min read
·
Dan Samorodnitsky
Autoimmune disease
Cabaletta’s CAR T Therapy Spurs Remissions in Small Lupus Trial
Phase I/II data for rese-cel point to its therapeutic potential in systemic lupus erythematosus and lupus nephritis, as well as other autoimmune conditions.
October 28, 2025
·
2 min read
·
Tristan Manalac
1 of 67,161
Next
